Sarana Meditama Metropolitan Tbk

same

Overview

SAME Overview

PT Sarana Meditama Metropolitan Tbk is an Indonesia-based company primarily engaged in providing healthcare service by building and operating hospitals. The Company hospitals are operated under the brand name of EMC Healthcare. The Company's specialty centers include cardiovascular center; digestive and bariatric center, and fertility and laparoscopy center. EMC Healthcare consists of seven hospitals that provide health services, namely EMC Alam Sutera Hospital, EMC Cibitung Hospital, EMC Cikarang Hospital, EMC Pekayon Hospital, EMC Pulomas Hospital, EMC Tangerang Hospital, and EMC Sentul Hospital. The Company also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk. The Company's subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera, and PT Kedoya Adyaraya Tbk.

24681012ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: SAME

Main
Market Cap.
IDR 4.52Trillion

~$287.96M USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

SAME Valuation Metrics

264

IDR

Closing Price on 2024-04-05

Price to Equity

219.59

P/E

At 219.59x P/E TTM, SAME.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 23.8x).

Price to Book

1.24

P/B

At 1.24x P/B TTM, SAME.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Price to Sales

3.00

P/S

At 3.00x P/S TTM, SAME.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Valuing Sarana Meditama Metropolitan Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing Sarana Meditama Metropolitan Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
21.24x
Price/Forward Earnings
-
Enterprise Value/Revenue
3.53x
Enterprise Value/EBITDA
26.35x
PEG Ratio
-5.78x

Analyst Ratings

No analyst ratings available yet.

Valuation Recap of SAME stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 219.59x is above the ID market average of 8.22x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (23.78x). In fact, less than 25% of its peers trade at a higher P/E ratio than SAME.
Max 3
High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 1.24x is below the peers average of 1.80x in the Healthcare Equipment & Providers sector. In fact, less than 25% of its peers trade at a lower P/B ratio than SAME.●●
Max 3
Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 3.00x is similar to the peers average of 3.00x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of SAME's valuation relative to its current sales and future earnings growth.
Max 2
Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. SAME's P/CF ratio of 21.24x is considered a relatively high ratio by analysts.
Max 2
Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. SAME's EV/R ratio of 3.53x is considered a relatively high ratio The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.98x.
Max 3

Peers

SAME Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk68.46T27.18T 30.31T 2.96T 23.123.31
MIKAPT Mitra Keluarga Karyasehat Tbk.39.22T7.11T 4.13T 0.95T 41.297.01
SILOPT Siloam International Hospitals Tbk.32.40T10.75T 10.83T 1.11T 29.294.28
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.62T 2.35T -0.05T -433.0911.10
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk20.25T3.75T 3.61T 0.97T 20.865.94
HEALPT Medikaloka Hermina Tbk.19.03T8.52T 5.54T 0.48T 39.485.15
PRAYPT Famon Awal Bros Sedaya Tbk9.42T4.42T 1.70T 0.18T 53.643.42
TSPCTempo Scan Pacific Tbk9.09T11.31T 12.93T 1.41T 6.431.18
SOHOPT Soho Global Health Tbk6.24T4.67T 7.91T 0.34T 18.422.45
OMEDPT Jayamas Medica Industri Tbk5.33T2.46T 1.63T 0.22T 23.782.50
Competitiveness Recap of SAME stock
WeightNotesScore
High
At a market cap of IDR 4,524.54 billion, SAME.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.
Max 2
High
At a PE of 219.59, SAME.JK ranks 1 out of 10 companies in the Healthcare sector for P/E value. The average PE is 1.90 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. false●●
Max 2
Medium
At a PE of 219.59, SAME.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 23.78). false●●
Max 2
Medium
At a revenue of IDR 1.51 trillion, SAME.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.
Max 2
Medium
At a profit of IDR 0.02 trillion, SAME.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.
Max 2

Future

Future Growth of SAME

Growth Forecasts

SAME 2024 Revenue Growth
-18.2%
SAME 2024 EPS Growth
0.0%
Sector Revenue Growth
+23.7%
Healthcare Equipment & Providers
Indonesia Market Growth
+12.0%
IDX overall growth
Healthcare Equipment & Providers Sector Revenue Growth '24
+23.0%
Healthcare Sector Revenue Growth '24
+17.1%

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 23.68% against the IDX average of +12.0%.

Healthcare Equipment & Providers sector overview

SAME Earnings & Revenue Forecast

All values in IDR billion

Future growth prospect of SAME
WeightNotesScore
High
SAME's projected growth rate of 23.68% is above the ID market average of 11.98%.●●●
Max 3
High
The Healthcare Equipment & Providers sub-sector is projected to grow revenue by 22.97% in 2024. This number is higher than the previous year 2023's growth rate of 9.96%. This bodes well for SAME's revenue growth prospects in the next 2 years. ●●●
Max 3
Medium
The Healthcare Equipment & Providers sub-sector is projected to increase earnings by 29.75% in 2024. This number is higher than the previous year 2023's EPS growth of 9.77%. This bodes well for SAME's earnings growth prospects in the next 2 years. ●●●
Max 3
Medium
SAME and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a fruitful year heading into 2024. Specifically, earnings are projected to increase by 16.30% in 2024 while revenue growth is projected to increase by 17.10%. These macroeconomic trends will likely be a tailwind for SAME's earnings growth prospects in the next 2 years. ●●
Max 3
Loading...
Loading...

Management

Executive Management

President Director

Jusup Halimi15.2 years

Vice President Director

Juniwati Gunawan15.4 years
Meta Dewi Thedja
Director
Drg. Nailufar, Mars
Director
Kusmiati
Director
Armen Antonius Djan
Director
NamePositionShares%
Armen Antonius DjanDirector400,000< 0.01
Drg. Nailufar, MarsDirector350,000< 0.01
Juniwati GunawanVice President Director400,000< 0.01
Jusup HalimiPresident Director830,000< 0.01
KusmiatiDirector350,000< 0.01
Meta Dewi ThedjaDirector350,000< 0.01
Expressed in millions IDR, unless otherwise stated

Ownership

SAME Ownership

Others
21.64%
Insiders
78.23%
Institutions
0.13%
NameNumber of SharesOwnership (%)Value
Pt Elang Mahkota Teknologi Tbk13,341,512,64577.93,522.16B
Public3,794,189,90022.11,001.67B

Largest Institutional Buy

No data is available for SAME at the moment.

Largest Institutional Sell

Dimensional Fund Advisors LP
Sold 31-12-2023
-759,603 shares

Institutional Transactions

Tracking institutional transactions buying / selling of SAME stock